No vaccine-related death in Baguio; 97% of Covid deaths unvaccinated

Bontoc Mayor Franklin Odsey and Municipal Health Officer Dr. Diga Kay Gomez receive from Office of the Congressman Chief of Staff, Atty. Cyphrine Maxcel Dalog, 190 pieces of reading glasses, two boxes of Woman’s Prenatal, one box of fabric bandages, three bags of N95masks, and 200 small boxes of Amlodipine on September 23, 2021, at the Mayor’s Office, Bontoc Municipal Capitol.** Jovi T. Lopez, Bontoc LGU

22 September 2021 – No death directly related to Coronavirus disease (COVID-19) vaccines has been recorded in the city as of Sept. 19, according to the City Health Service Office.
The city has administered a total of 304,353 doses as of Sept. 18 and has fully vaccinated 127,811 persons or 45.48 percent of the city’s eligible population of 18 years old and above.
Of the 374 deaths recorded since the start of the vaccination last March 2 up to Sept. 15, ten or 2.674 percent were vaccinated while 364 or 97.326 percent were unvaccinated.
The City Health Services Office under Dr. Rowena Galpo said death incidents involving vaccinated persons in the city undergo intensive investigation by the Regional Adverse Events Following Immunization Committee (RAEFIC) composed of specialists on vaccinology, infectious disease and allergy.
The committee AEFI gathers every week to deliberate on the death incident involving a vaccinated person to determine and establish whether or not the death was caused by the vaccine. The findings will then be reviewed and validated by the National AEFIC.
The experts use not only one but several gauges or bases in their investigations.
The World Health Organization said that while the vaccines help lower the chances of developing severe symptoms or dying, some people still die but most likely this is due to factors such as age risks and comorbidities.
The CHSO said the death incidence decreased considerably after the city rolled out its vaccination program for senior citizens or A2 in the vaccination priority list and persons with comorbidities (A3). ** Aileen P. Refuerzo

Leave a Reply

Your email address will not be published. Required fields are marked *

five + 7 =